Continuous glucose monitoring for type 2 diabetes on insulin
Part of Hormones & metabolism clinical trials.
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin. It aims to see if one method helps manage glucose better, which could improve daily control and long-term health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 35 years or older.
- You have type 2 diabetes and use insulin injections (one or more per day).
- Your most recent A1C test result is above 7.0%.
- Your insulin dose and other diabetes medications have been stable for the past 3 months.
- Your fasting blood sugar is between 70 and 130 mg/dL.
- You have a smartphone that supports NFC (near-field communication) technology.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
This real-world study tests whether using a continuous glucose monitor (isCGM) with or without pharmacist coaching helps people with type 2 diabetes who are not on insulin improve their blood sugar control. It compares these approaches to standard blood sugar checking and looks for better HbA1c results after three months.
This study checks whether using a continuous glucose monitor (CGM, a sensor that tracks blood sugar) is practical and helpful for people with type 2 diabetes in primary care settings. It focuses on people who may have a harder time getting diabetes support and have higher A1c levels.
This study gives continuous glucose monitors (CGMs) to people with type 2 diabetes who cannot afford them. It looks at whether using a CGM helps improve blood sugar control.
This trial is testing whether using a continuous glucose monitor (CGM) for different lengths of time helps people with type 2 diabetes understand their blood sugar patterns. You won't need to change your current diabetes medications.
This study uses a continuous glucose monitor (a small sensor that tracks blood sugar levels) along with a special drink test to find early signs of diabetes. It may help people who are at risk or have early blood sugar problems get a clearer picture of their health.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.